SCHEMBL10114545

SCHEMBL10114545

CC(=O)Oc1cc(F)c(C(=O)Nc2ncc(S(C)(=O)=O)s2)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 17/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
MLNR O43193 1/20 0.41
NR1I2 O75469 1/20 0.41
ABCB11 O95342 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
ADRB2 P07550 1/20 0.41
CHRM2 P08172 1/20 0.41
ADRB1 P08588 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADRA2A P08913 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
MAPT P10636 1/20 0.41
CHRM1 P11229 1/20 0.41
DRD2 P14416 1/20 0.41
PKM P14618 1/20 0.41
AKR1B1 P15121 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10114566 0.91 ALDH1A1 (0.45) SCN9AMEN1NPC1MLNRNR1I2
SCHEMBL4756645 0.84 NPC1 (0.41) MEN1NPC1MLNRNR1I2ABCB11
SCHEMBL4757204 0.84 FFAR2 (0.44) SCN9ANPC1RAB9ASMN1; SMN2FFAR2
SCHEMBL10114349 0.84 FFAR2 (0.43) SCN9AMEN1NPC1MLNRNR1I2
SCHEMBL10114630 0.80 SCN9A (0.41) SCN9A
SCHEMBL10114555 0.79 FFAR2 (0.44) MEN1NPC1MLNRNR1I2ABCB11
SCHEMBL10114380 0.79 ALDH1A1 (0.52) MEN1NPC1MLNRNR1I2ABCB11
SCHEMBL705921 0.78 ALDH1A1 (0.64) MEN1NPC1MLNRNR1I2ABCB11
SCHEMBL4756649 0.77 FFAR2 (0.44) MEN1NPC1MLNRNR1I2ABCB11
SCHEMBL10114354 0.77 FFAR2 (0.44) MEN1NPC1MLNRNR1I2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2178852-B9 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LAB LC (US) 2016-06-22 EP disclosed
EP-2178852-B1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LAB LC (US) 2015-07-22 EP disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC SCN9A 3086/4885MEN1 4564/4885NPC1 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.